AVTR
Price
$10.74
Change
-$0.40 (-3.59%)
Updated
Feb 5, 02:25 PM (EDT)
Capitalization
7.6B
6 days until earnings call
Intraday BUY SELL Signals
BLFS
Price
$22.28
Change
-$0.39 (-1.72%)
Updated
Feb 5, 02:29 PM (EDT)
Capitalization
1.09B
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVTR vs BLFS

Header iconAVTR vs BLFS Comparison
Open Charts AVTR vs BLFSBanner chart's image
Avantor
Price$10.74
Change-$0.40 (-3.59%)
Volume$15.7K
Capitalization7.6B
BioLife Solutions
Price$22.28
Change-$0.39 (-1.72%)
Volume$100
Capitalization1.09B
AVTR vs BLFS Comparison Chart in %
AVTR
Daily Signal:
Gain/Loss:
BLFS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AVTR vs. BLFS commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTR is a Hold and BLFS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (AVTR: $11.14 vs. BLFS: $22.67)
Brand notoriety: AVTR and BLFS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AVTR: 158% vs. BLFS: 204%
Market capitalization -- AVTR: $7.6B vs. BLFS: $1.09B
AVTR [@Pharmaceuticals: Other] is valued at $7.6B. BLFS’s [@Pharmaceuticals: Other] market capitalization is $1.09B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.93B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTR’s FA Score shows that 0 FA rating(s) are green whileBLFS’s FA Score has 1 green FA rating(s).

  • AVTR’s FA Score: 0 green, 5 red.
  • BLFS’s FA Score: 1 green, 4 red.
According to our system of comparison, BLFS is a better buy in the long-term than AVTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTR’s TA Score shows that 5 TA indicator(s) are bullish while BLFS’s TA Score has 4 bullish TA indicator(s).

  • AVTR’s TA Score: 5 bullish, 5 bearish.
  • BLFS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AVTR is a better buy in the short-term than BLFS.

Price Growth

AVTR (@Pharmaceuticals: Other) experienced а +0.81% price change this week, while BLFS (@Pharmaceuticals: Other) price change was -1.18% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.19%. For the same industry, the average monthly price growth was -1.97%, and the average quarterly price growth was +23.00%.

Reported Earning Dates

AVTR is expected to report earnings on Feb 11, 2026.

BLFS is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVTR($7.6B) has a higher market cap than BLFS($1.09B). AVTR YTD gains are higher at: -2.792 vs. BLFS (-6.245). AVTR has higher annual earnings (EBITDA): 645M vs. BLFS (-14.25M). AVTR has more cash in the bank: 252M vs. BLFS (79M). BLFS has less debt than AVTR: BLFS (20.7M) vs AVTR (3.86B). AVTR has higher revenues than BLFS: AVTR (6.58B) vs BLFS (100M).
AVTRBLFSAVTR / BLFS
Capitalization7.6B1.09B696%
EBITDA645M-14.25M-4,525%
Gain YTD-2.792-6.24545%
P/E Ratio14.93N/A-
Revenue6.58B100M6,575%
Total Cash252M79M319%
Total Debt3.86B20.7M18,638%
FUNDAMENTALS RATINGS
AVTR vs BLFS: Fundamental Ratings
AVTR
BLFS
OUTLOOK RATING
1..100
586
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9090
PRICE GROWTH RATING
1..100
7862
P/E GROWTH RATING
1..100
9915
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVTR's Valuation (76) in the null industry is in the same range as BLFS (99) in the Medical Specialties industry. This means that AVTR’s stock grew similarly to BLFS’s over the last 12 months.

AVTR's Profit vs Risk Rating (100) in the null industry is in the same range as BLFS (100) in the Medical Specialties industry. This means that AVTR’s stock grew similarly to BLFS’s over the last 12 months.

AVTR's SMR Rating (90) in the null industry is in the same range as BLFS (90) in the Medical Specialties industry. This means that AVTR’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Price Growth Rating (62) in the Medical Specialties industry is in the same range as AVTR (78) in the null industry. This means that BLFS’s stock grew similarly to AVTR’s over the last 12 months.

BLFS's P/E Growth Rating (15) in the Medical Specialties industry is significantly better than the same rating for AVTR (99) in the null industry. This means that BLFS’s stock grew significantly faster than AVTR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTRBLFS
RSI
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 8 days ago
72%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
AVTR
Daily Signal:
Gain/Loss:
BLFS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSSCX19.380.24
+1.25%
Columbia Small Cap Value Discv C
PISOX15.220.16
+1.06%
Columbia Pyrford International Stk Ins 2
RLSMX12.480.06
+0.48%
Lazard US Small Cap Equity Select R6
FFIDX113.15N/A
N/A
Fidelity
IGLGX20.56-0.50
-2.37%
Columbia Select Global Equity A

AVTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTR has been loosely correlated with SMTI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTR jumps, then SMTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTR
1D Price
Change %
AVTR100%
+2.67%
SMTI - AVTR
48%
Loosely correlated
+0.92%
ATR - AVTR
48%
Loosely correlated
+4.09%
RGEN - AVTR
47%
Loosely correlated
-2.74%
BLFS - AVTR
45%
Loosely correlated
-0.74%
BAX - AVTR
44%
Loosely correlated
+5.63%
More

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
-0.74%
RGEN - BLFS
56%
Loosely correlated
-2.74%
SMTI - BLFS
52%
Loosely correlated
+0.92%
RVTY - BLFS
51%
Loosely correlated
+2.67%
A - BLFS
50%
Loosely correlated
+0.64%
AZTA - BLFS
47%
Loosely correlated
-22.81%
More